COMBINATION OF DRUGS IN NEW CANCER TREATMENT WIPES OUT TUMOURS IN TERMINALLY ILL

Tue 12 October 2021:

Scientists have discovered that a new cancer treatment can eradicate tumors in terminally ill patients.

According to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS foundation trust, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival.”

Speaking to The Guardian, one patient, who was expected to die four years ago, said that he was told by the nurses that his tumour had “completely disappeared.” The 77-year-old grandfather is now cancer-free and spent last week on a cruise with his wife.

This is because the combination of nivolumab and ipilimumab medications led to a reduction in the size of tumours in the terminally ill head and neck patients.

Combining the two immunotherapy treatments, according to experts, could prove to be an effective new weapon against different cancers.

The immunotherapy treatment also had far less side effects, according to the researchers, as compared to “extreme” chemotherapy, which is the standard treatment for many patients with advanced cancer.

Professor Kristian Helin, the ICR chief executive, while speaking with The Guardian said, “These are promising results.”

“Immunotherapies are kinder, smarter treatments that can bring significant benefits to patients.”

FILE PHOTO

_____________________________________________________________________________

FOLLOW INDEPENDENT PRESS:

TWITTER (CLICK HERE)
https://twitter.com/IpIndependent